Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Similar documents
Opioid Use Issues: All the Players

2/21/2018. What are Opioids?

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Opiate Use Disorder and Opiate Overdose

Treatment Team Approaches in Substance Abuse Treatment

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Strategies to Manage The Opioid Crisis

Appendix F Federation of State Medical Boards

The Changing Face of Heroin Use in the US: A Retrospective Analysis of the Past 50 Years 100 Heroin 90 Prescription opioids

Overview of Opioid Use Disorder

Responding to the Opioid Epidemic: Behavioral Health Specialists Role on the Interprofessional Team

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

OPIOID EPIDEMIC IN CENTRAL OKLAHOMA YOUTH

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Hospitals Role in Addressing the Opioid Crisis

Serious Mental Illness and Opioid Use Disorder

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER

Medicated Assisted Treatment

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

MAT in the Corrections Setting

Opioids and Opioid Addiction: Practical Management Approaches

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

Acute General Medical and Surgical Admission:

Opioid Use in Youth. Amy Yule M.D. March 2,

Naltrexone for Opioid Use Disorder. A Project RAMP Resource Adam J. Gordon, MD MPH FACP DFASAM CMRO December 2017

Prescription Opioids

Neurobiology of Drug Abuse and Addiction PSYC 450

The opioid crisis: A view from NIDA

Optimizing Suboxone in Opioid Addicts

Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine

SAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017

History of Present Illness (HPI) Assessment and Plan Template

MAT 101: TREATMENT OF OPIOID USE DISORDER

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Identification and Treatment of Opioid Use Disorders in Primary Care Settings

Opioid Deaths Quadruple Since 1999

Tapering Opioids Best Practices*

Epidemiologic Data on Opioid Use: Changing Problems

Opioid Withdrawal, Opioid Substitution, and HIV Infection

The Opioid Epidemic: HHS Response

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی

Opioids. October 29, Addiction Medicine Review Course CSAM, Newport Beach, CA

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

Substance Use Disorders

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

THE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Prescription Opioids: The Real Story 4/30/15

Barriers to treatment among non-treatment engaged individuals with opioid use disorder. Patricia Cavazos-Rehg, Ph.D.

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5

Addictions 101: Understanding, Recognizing, and Treating the Disease State!

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Opioid Use Disorder OCTOBER 2018

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Didactic Series. Opioid Dependence and HIV Care. Theo Katsivas, MD MAS, AAHIVS Associate Clinical Professor Owen Clinic, UCSD 10/25/2018

Advancing Addiction Science to Address the Opioid Crisis

Advances in Clinical Research for Prescription Opioid Dependence

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

Module Three Screening and Assessment V

Opioid Use and Other Trends

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Management of Opioid Use Disorder in Primary Care

Aligning Evidence-Based Practices with CCBHC Financing, Operations, and Quality Reporting. October 25th, :00pm 3:00pm

Heroin. What is heroin?

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Building capacity for a CHC response to Ontario's Opioid Crisis

Medication for the Treatment of Addiction (MAT)

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017

Hospital Based Opioid Management A case based, peer discussion

TennCare s Opioid Strategy

Substance Use and Addiction. Presentation for Physicians and Other Health Care Providers JOHN HARSANY JR. M.D. F.A.S.A.M.

Buprenorphine for Family Medicine. Hannah Snyder, MD Addiction Medicine Fellow, UCSF 12/7/17

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Opioid Crisis: HHS Strategy and Advancing Pain Management

CDC s Efforts to End the Opioid Epidemic

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Treatment Approaches for Drug Addiction

Treatment of Opioid Use Disorder

Treatment of Opioid Use Disorder

Pain, Suffering, Over-Prescribing and Addiction What Have We Done, What Can We Do?

Preventing Prescription Drug and Heroin Abuse and Deaths: Practical Strategies. July 12, 2015

Transcription:

Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC

Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01 DA030300 HHSD2002013M53964B /200-2016-F-92304 Research Career Development Award No conflicts of interest 2

Among the remedies which it has pleased Almighty God to give to man to relieve his sufferings, none is so universal and so efficacious as opium. Sydenham, 1682 3

Rates of Opioid Overdose Deaths, Sales, and Treatment Admissions, United States, 1999 2010 4 Source: CDC. (2011). Vital signs: Overdoses of prescription opioid pain relievers United States, 1999 2008. Morbidity and Mortality Weekly Report, 60(43),1487-1492. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm60e1101a1.htm?s_cid=mm60e1101a1_w

Drug Overdose Death Rate, 2008, and Opioid Pain Reliever Sales Rate, 2010 National Vital Statistics System, 2008; Automated Reports Consolidated Orders System, 2010. Kg of opioid pain relievers used per 10,000 Age-adjusted rate per 100,000 5

Commonly Used Opioids Prescription opioids, such as oxycodone, hydrocodone, morphine, dilaudad, fentanyl, methadone, buprenorphine Heroin Illicit fentanyl Most initial use is with prescription opioids 1 1 Compton, W. M., Jones, C. M., Baldwin, G. T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine, 374,154-163. 6

Opioid Use Disorder Criteria Formerly divided into abuse and dependence Combined into Opioid Use Disorders in DSM 5 2 1.9 million people with an opioid use disorder related to prescription opioids 3 586,000 people with an opioid use disorder related to heroin use 3 7 2 American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author. 3 SAMHSA. (2015). Substance use disorders. Retrieved from https://www.samhsa.gov/disorders/substance-use

Opioid Use Disorder Criteria (continued) DSM 5 Criteria requires at least 2 out of 11 1. Taken in larger amounts or for longer periods of time than intended 2. Persistent desire or unsuccessful efforts to cut down or control use 3. Great deal of time is spent in activities necessary to obtain the opioid, use the opioid, or recover from its effects. 4. Craving 5. Recurrent opioid use resulting in a failure to fulfill major role obligations 8 Source: American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

Opioid Use Disorder Criteria (continued) 6. Continued opioid use despite persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of opioids 7. Important activities are given up or reduced because of opioid use 8. Recurrent opioid use in situations where it is hazardous 9. Continued opioid use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely caused or exacerbated by opioids 10. Tolerance 9 11. Withdrawal Source: American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

Opioid Use Disorder Criteria (continued) One problem with diagnosing opioid use disorders (OUDs) among individuals using chronic opioid therapy for chronic non-cancer pain is that almost all of these individuals will have tolerance and withdrawal. 10

Non-medical Prescription Opioid Use Use of prescription opioids not prescribed for the individual or taken only for the experience or feeling it caused 4 2.5 million people in the United States 5 Many people move from non-medical prescription opioid use to opioid use disorder 6 11 4 Substance Abuse and Mental Health Services Administration 5 Hughes, A., Williams, M. R., Lipari, R. N., Bose, J., Copello, E. A. P., & Kroutil, L. A. (2016). Prescription drug use and misuse in the United States: Results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review. Retrieved from https://www.samhsa.gov/data/sites/default/files/nsduh-ffr2-2015/nsduh-ffr2-2015.htm 6 Compton, W. M., Jones, C. M., Baldwin, G. T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine, 374,154-163.

Negative Sequalae Crime Mortality from overdose Hepatitis C, HIV Others 12

Treatment 12-step groups Cognitive behavioral therapy (enhance motivation, work towards behavioral change, reward treatment with adherence, teach ways to minimize relapse) Medication-assisted treatment Methadone opioid agonist Buprenorphine opioid partial agonist Naltrexone opioid antagonist 13 Source: Schuckit, M. A. (2016). Treatment of opioid use disorders. New England Journal of Medicine, 375, 357-368.

Thanks! Please email any questions to medlund@rti.org 14